Antibiotice S.A.
- Address
- Str Valea Lupului Nr 1, 707410 Iasi, Romania
Antibiotice S.A. — Gastrointestinal and Musculoskeletal Research
Clinical research at this Clinical Trials Center in Iasi, Romania, focuses on digestive system diseases and musculoskeletal diseases, with studies designed to compare how established treatments perform in healthy subjects and to support the development of new therapeutic options.
- Evaluation of treatments for digestive system diseases, including gastrointestinal conditions such as acid-related disorders and intestinal infections.
- Research in musculoskeletal diseases aimed at understanding treatment performance for pain and inflammation-related needs.
- Studies involving healthy subjects to assess whether products match the effects of reference medicines.
The site’s work centers on bioequivalence research, helping determine whether locally developed medicines can offer comparable effectiveness and safety to well-known treatments.
Antibiotice S.A. — Anti-Infective and Urogenital Studies
Another key area of research at Antibiotice S.A. is bacterial infections and mycoses, alongside female urogenital diseases and male urogenital diseases, with trials focused on common infectious and urinary health conditions in healthy volunteers.
- Studies of bacterial infections that examine treatment options for infection control.
- Research in fungal diseases and related anti-infective therapy.
- Clinical work addressing female urogenital diseases and male urogenital diseases to support better treatment matching.
These trials are primarily intended to compare medicines with established reference products and to improve confidence in how treatments may perform in everyday care.
Physiological and Supportive Care Research
The site also includes research linked to musculoskeletal and neural physiological phenomena, reflecting interest in how medicines interact with body functions relevant to pain, mobility, and related supportive care needs.
- Investigation of musculoskeletal and neural physiological phenomena connected to treatment response.
- Clinical comparisons that help clarify the practical use of medicines in routine therapeutic settings.
- Work supporting the assessment of product performance in general health populations.
Overall, the research activity is centered on testing medicine equivalence and strengthening the evidence base for accessible treatment options across several therapeutic areas.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Antibiotice S.A.1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Antibiotice S.A.7trials
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 442 other sites in Romania
Therapeutic Area Benchmark — Romania
Select a therapeutic area to compare against other sites in Romania.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Romania
Market Share
Country: Romania
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Antibiotice S.A.
lock Showing 1 of 7 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Bioequivalence Study of Cefixime 400 mg Hard Capsules Versus Cefixime 400 mg Film-Coated Tablets in Healthy Subjects | Antibiotice S.A. | Phase I | Not Recruiting | Jun 2023 | Jul 2023 |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Cefixime | 1 | Unknown | 2023-06-12 | 2023-06-12 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.